Sign up to save your podcasts
Or
Share Bispecific Antibodies: The Case for Non-BCMA Targets
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Bispecific Antibodies: The Case for Non-BCMA Targets
Join Dr Chari as he reviews the rationale and clinical evidence of novel non-BCMA-targeted bispecific antibodies for patients with R/R multiple myeloma.
Credit available for this activity expires: 6/10/2022
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/952772?src=mkm_podcast_addon_952772
View all episodes
By Medscape Podcasts
4
77 ratings
Join Dr Chari as he reviews the rationale and clinical evidence of novel non-BCMA-targeted bispecific antibodies for patients with R/R multiple myeloma.
Credit available for this activity expires: 6/10/2022
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/952772?src=mkm_podcast_addon_952772
More shows like Keeping Current
View all
NEJM This Week
320 Listeners
JAMA Clinical Reviews
496 Listeners
WSJ Tech News Briefing
1,641 Listeners
This Week in Cardiology
882 Listeners
The Bob Harrington Show
14 Listeners
One-on-One with Eric Topol
16 Listeners
Mayo Clinic Talks
292 Listeners
The Curbsiders Internal Medicine Podcast
3,351 Listeners
The Peter Attia Drive
8,527 Listeners
Annals On Call Podcast
193 Listeners
JAMA Medical News
93 Listeners
The Clinical Problem Solvers
512 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
369 Listeners
Medicine and the Machine
61 Listeners
Keeping Current CME
28 Listeners
Cardionerds: A Cardiology Podcast
425 Listeners
The Curious Clinicians
374 Listeners
Huberman Lab
29,183 Listeners
Not Otherwise Specified
65 Listeners